Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ella Ariza-Heredia MD

Ella Ariza-Heredia MD

Associate Professor of Medicine, Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas

Ella Ariza-Heredia, MD, is Associate Professor in the Department of Infectious Diseases, Infection Control and Employee Health at the University of Texas MD Anderson Center. She is the Clinical Director of the Infectious Diseases Hematopoietic Stem Cell Transplantation, Lymphoma and Multiple Myeloma service. Dr. Ariza-Heredia main research focus includes viral infections and optimizing immunization vaccination of this specific immunocompromised population. Dr Ariza-Heredia has conducted clinical trials on areas including CMV vaccine, CMV immunomonitoring and novel antiviral therapies, as well as vaccination practices in immunocompromised host. She has over 50 peer-review publications, and several book chapters and abstracts. Funding sources: Private industry and Institutional awards.

 

Disclosures

Dr. Ariza-Heredia has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Safety and Antibody Response After mRNA Vaccine in Allogeneic HSCT Recipients

Recently Updated